awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33785136-13719DE1-F314-41E2-AA2F-54F833964684
Q33785136-13719DE1-F314-41E2-AA2F-54F833964684
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33785136-13719DE1-F314-41E2-AA2F-54F833964684
Dapagliflozin added to glimepiride in patients with type 2 diabetes mellitus sustains glycemic control and weight loss over 48 weeks: a randomized, double-blind, parallel-group, placebo-controlled trial.
P2860
Q33785136-13719DE1-F314-41E2-AA2F-54F833964684
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33785136-13719DE1-F314-41E2-AA2F-54F833964684
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
61c42b525c7c41a10ed92aee9843942ff35079eb
P2860
Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes.